Emmessar Biotech & Nutrition
Emmessar Biotech & Nutrition Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Emmessar Biotech & Nutrition
Start SIPEmmessar Biotech & Nutrition Investment Rating
-
Master Rating:
-
Emmessar Biot.& Nut. has an operating revenue of Rs. 0.88 Cr. on a trailing 12-month basis. An annual revenue growth of 21% is outstanding, Pre-tax margin of 95% is great, ROE of 7% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 45 which is a POOR score indicating inconsistency in earnings, a RS Rating of 20 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 100 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses Qtr Cr | 0 | 0 | 1 | 0 | 0 | 0 |
Operating Profit Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
Net Profit Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
Emmessar Biotech & Nutrition Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 4
- Bearish Moving Average
- ___
- 12
- 20 Day
- ₹25.51
- 50 Day
- ₹25.15
- 100 Day
- ₹24.98
- 200 Day
- ₹25.16
- 20 Day
- ₹25.5
- 50 Day
- ₹24.98
- 100 Day
- ₹24.61
- 200 Day
- ₹25.22
Emmessar Biotech & Nutrition Resistance and Support
Resistance | |
---|---|
First Resistance | ₹25.61 |
Second Resistance | ₹26.19 |
Third Resistance | ₹26.49 |
RSI | 47.58 |
MFI | 72.81 |
MACD Single Line | 0.29 |
MACD | 0.27 |
Support | |
---|---|
First Resistance | ₹24.73 |
Second Resistance | ₹24.43 |
Third Resistance | ₹23.85 |
Emmessar Biotech & Nutrition Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 1,754 | 155,404 | 88.6 |
Week | 3,145 | 262,943 | 83.6 |
1 Month | 4,248 | 341,211 | 80.32 |
6 Month | 2,825 | 227,741 | 80.61 |
Emmessar Biotech & Nutrition Result Highlights
Emmessar Biotech & Nutrition Synopsis
BSE-Medical-Biomed/Biotech
Emmessar Biotech belongs to the Industry of Chemicals - Inorganic - Others. Company’s Total Operating Revenue is Rs. 1.02 Cr. and Equity Capital is Rs. 5.00 Cr. for the Year ended 31/03/2023. Emmessar Biotech & Nutrition Ltd. is a Public Limited Listed company incorporated on 17/03/1992 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24110MH1992PLC065942 and registration number is 065942.Market Cap | 12 |
Sales | 1 |
Shares in Float | 0.21 |
No of funds | 4 |
Yield |
Book Value | 1.88 |
U/D Vol ratio | 0.9 |
LTDebt / Equity | |
Alpha | |
Beta | 0.3 |
Emmessar Biotech & Nutrition
Owner Name | Jun-23 | Mar-23 | Dec-22 | Sep-22 |
---|---|---|---|---|
Promoters | 58.19% | 59.08% | 58.53% | 58.19% |
Mutual Funds | 0.05% | 0.05% | 0.05% | 0.05% |
Financial Institutions/ Banks | 0.14% | 0.14% | 0.14% | 0.14% |
Individual Investors | 39.56% | 38.38% | 38.84% | 39.54% |
Others | 2.06% | 2.35% | 2.44% | 2.08% |
Emmessar Biotech & Nutrition Management
Name | Designation |
---|---|
Mr. Ashok M Kadakia | Chairman & Ind.Director |
Mr. MSR Ayyangar | Managing Director |
Mr. Jeyavel B Nadar | Executive Director |
Mr. Anantharama S Subramanian | Independent Director |
Mr. Vijay K Agrawal | Independent Director |
Dr.(Mrs.) Anuradha S Raghavan | Non Executive Director |
Dr.(Mrs.) Sarada S Raghavan | Non Executive Director |
Mrs. Rajalakshmi Srinivasa Raghavan | Addnl. & Non Exe.Director |
Emmessar Biotech & Nutrition Forecast
Price Estimates
Emmessar Biotech & Nutrition Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-08-10 | Quarterly Results | |
2023-05-20 | Audited Results | |
2023-02-04 | Quarterly Results | |
2022-10-20 | Quarterly Results | |
2022-08-08 | Quarterly Results |
- Company Name
- CMP
- Chg(%)
- IndusInd Bank
- 1453
- 2.9
- Maruti Suzuki
- 10535
- 2.4
- St Bk of India
- 598
- 1.7
- M & M
- 1607
- 1.5
- Bajaj Finserv
- 1544
- 1.1
- Company Name
- CMP
- Chg(%)
Emmessar Biotech & Nutrition FAQs
What is Share Price of Emmessar Biotech & Nutrition ?
Emmessar Biotech & Nutrition share price is ₹25 As on 23 September, 2023 | 00:46
What is the Market Cap of Emmessar Biotech & Nutrition ?
The Market Cap of Emmessar Biotech & Nutrition is ₹12.5 Cr As on 23 September, 2023 | 00:46
What is the P/E ratio of Emmessar Biotech & Nutrition ?
The P/E ratio of Emmessar Biotech & Nutrition is 34.3 As on 23 September, 2023 | 00:46
What is the PB ratio of Emmessar Biotech & Nutrition ?
The PB ratio of Emmessar Biotech & Nutrition is 1.9 As on 23 September, 2023 | 00:46